Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials
about
Moxifloxacin monotherapy versus combination therapy in patients with severe community-acquired pneumonia evoked ARDS.Treatment of community-acquired pneumonia with moxifloxacin: a meta-analysis of randomized controlled trials.Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database.Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Comparative Outcome Analysis of Penicillin-Based Versus Fluoroquinolone-Based Antibiotic Therapy for Community-Acquired Pneumonia: A Nationwide Population-Based Cohort StudyProposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic.Emerging drugs for pneumococcal pneumonia.Elderly patients with community-acquired pneumonia: optimal treatment strategies.What Is New in Antibiotic Therapy in Community-Acquired Pneumonia? An Evidence-Based Approach Focusing on Combined Therapy.The Value of Macrolide-Based Regimens for Community-Acquired Pneumonia.Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment.Study conclusions should reflect results.Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia.The dilemma of monotherapy or combination therapy in community-acquired pneumonia.Are fluoroquinolones superior antibiotics for the treatment of community-acquired pneumonia?High-dose levofloxacin in community-acquired pneumonia: a randomized, open-label study.The efficacy of high-dose penicillin G for pneumococcal pneumonia diagnosed based on initial comprehensive assessment at admission: an observational study.
P2860
Q33801234-69694CDC-E746-40A5-9CAA-FB15F1274271Q34488843-A0768333-51C0-4A51-ACB0-FFB2167313A8Q36195774-3F32E9B6-9A23-4778-A94F-5A947BB36D6BQ36281234-69FA931C-1862-46FD-AE8F-C8D8188C7463Q36581089-01F6C813-A70A-4211-8A38-11E0978A5A73Q37697321-7248C42E-504C-49B2-8FD7-3CF1ACC94AF6Q37864327-BE16D0C1-79FC-4AE0-A0B7-E2692196A9EFQ37896600-EC1E4489-7BE1-4AF3-ABE4-BFD87E82FEB4Q38571891-6D647638-C352-44B6-AF9B-DE7B99300B22Q38601840-D7A14B11-2926-402B-AEFA-3EB98918A395Q38963042-2A2C6698-A39A-494A-A981-D5A805095DF1Q46117109-2876807F-4F6A-44A5-AA55-4926A52EDEFFQ46887329-BE393767-4F6D-4D8A-8AB5-A5CB6CD3291AQ47291065-A2BE06BF-D5DF-428C-A5BE-60182070EC43Q48023992-1882C600-BC41-4F12-944B-E0F52B68B29FQ53127457-5C56DDC8-451F-4011-909C-09A4363253DEQ55442896-C78E3811-F010-4C9B-AD3D-2BC0AF6CA32C
P2860
Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Respiratory fluoroquinolones f ...... f randomized controlled trials
@ast
Respiratory fluoroquinolones f ...... f randomized controlled trials
@en
Respiratory fluoroquinolones f ...... f randomized controlled trials
@nl
type
label
Respiratory fluoroquinolones f ...... f randomized controlled trials
@ast
Respiratory fluoroquinolones f ...... f randomized controlled trials
@en
Respiratory fluoroquinolones f ...... f randomized controlled trials
@nl
prefLabel
Respiratory fluoroquinolones f ...... f randomized controlled trials
@ast
Respiratory fluoroquinolones f ...... f randomized controlled trials
@en
Respiratory fluoroquinolones f ...... f randomized controlled trials
@nl
P2093
P2860
P50
P356
P1476
Respiratory fluoroquinolones f ...... f randomized controlled trials
@en
P2093
Ilias I Siempos
Ioanna P Korbila
Zoe Athanassa
P2860
P304
P356
10.1503/CMAJ.080358
P407
P577
2008-12-02T00:00:00Z